Oncothyreon HomeContactSite MapGlossary
News & Events
 
Stock Information
NASDAQ: ONTY
$3.63   - 0.10
Jul 2, 2009
3:59 PM ET
TSX: ONY
$4.35   + 0.05
Jul 3, 2009
2:07 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Press Releases

All Releases
View Summary Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
Jun 22, 2009
PDF 13.7 KB Add to Briefcase
View Summary Oncothyreon appoints Scott Peterson as Vice President of Research and Development
Jun 15, 2009
PDF 12.1 KB Add to Briefcase
View Summary Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2009
PDF 17.0 KB Add to Briefcase
View Summary Oncothyreon announces closing of $11.1 million registered direct financing
May 27, 2009
PDF 9.8 KB Add to Briefcase
View Summary Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
May 20, 2009
PDF 10.0 KB Add to Briefcase
View Summary Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis
May 18, 2009
PDF 12.9 KB Add to Briefcase
View Summary Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
May 18, 2009
PDF 12.2 KB Add to Briefcase
View Summary Oncothyreon reports first quarter 2009 financial results
May 14, 2009
PDF 14.9 KB Add to Briefcase
View Summary Oncothyreon regains compliance with NASDAQ listing requirements
Mar 16, 2009
PDF 10.3 KB Add to Briefcase
View Summary Oncothyreon to present at Invest Northwest 2009
Mar 13, 2009
PDF 8.8 KB Add to Briefcase
View Summary Oncothyreon reports full year and fourth quarter 2008 financial results
Mar 9, 2009
PDF 16.5 KB Add to Briefcase
View Summary Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Mar 3, 2009
PDF 9.6 KB Add to Briefcase
View Summary Oncothyreon to present at BIO CEO & Investor Conference 2009
Feb 3, 2009
PDF 9.4 KB Add to Briefcase
View Summary Oncothyreon announces development plans and personnel changes and updates financial guidance
Dec 18, 2008
PDF 15.2 KB Add to Briefcase
View Summary Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon
Dec 18, 2008
PDF 14.0 KB Add to Briefcase
View Summary Oncothyreon reports third quarter 2008 financial results
Nov 6, 2008
PDF 15.9 KB Add to Briefcase
View Summary Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
Nov 4, 2008
PDF 9.4 KB Add to Briefcase
View Summary Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
Nov 3, 2008
PDF 9.6 KB Add to Briefcase
View Summary Oncothyreon to present at BIO Investor Forum 2008
Oct 24, 2008
PDF 9.4 KB Add to Briefcase
View Summary Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
Sep 17, 2008
PDF 12.4 KB Add to Briefcase
Showing 1-20 of 146 Page: 1 2 3 ... 8  Next 20
= add release to Briefcase

return to top ^

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events